Market Closed -
Hong Kong S.E.
04:08:27 2023-03-31 am EDT
|
5-day change
|
1st Jan Change
|
0.024
HKD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
177.3
|
81.46
|
186.1
|
271.8
|
899.7
|
343
|
Enterprise Value (EV)
1 |
526.6
|
377.5
|
495.7
|
769.1
|
1,011
|
503.4
|
P/E ratio
|
-0.54
x
|
-0.15
x
|
-0.36
x
|
-3.63
x
|
-5.44
x
|
-2.25
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.6
x
|
8.94
x
|
24.5
x
|
3.9
x
|
24.4
x
|
7.66
x
|
EV / Revenue
|
31.6
x
|
41.4
x
|
65.3
x
|
11
x
|
27.4
x
|
11.3
x
|
EV / EBITDA
|
10
x
|
-4.74
x
|
257
x
|
51.4
x
|
123
x
|
-10.8
x
|
EV / FCF
|
5.44
x
|
-3.31
x
|
22.5
x
|
-28.7
x
|
-23.4
x
|
-10.5
x
|
FCF Yield
|
18.4%
|
-30.2%
|
4.44%
|
-3.49%
|
-4.28%
|
-9.52%
|
Price to Book
|
0.29
x
|
1.9
x
|
-0.58
x
|
-0.72
x
|
29.6
x
|
-2.72
x
|
Nbr of stocks (in thousands)
|
479,082
|
479,185
|
729,793
|
937,172
|
4,454,197
|
4,454,197
|
Reference price
2 |
0.3700
|
0.1700
|
0.2550
|
0.2900
|
0.2020
|
0.0770
|
Announcement Date
|
4/26/18
|
4/29/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
16.67
|
9.109
|
7.587
|
69.77
|
36.93
|
44.75
|
EBITDA
1 |
52.46
|
-79.7
|
1.929
|
14.95
|
8.216
|
-46.51
|
EBIT
1 |
-24.38
|
-141.4
|
-23.05
|
0.956
|
-11.23
|
-66.27
|
Operating Margin
|
-146.26%
|
-1,551.85%
|
-303.76%
|
1.37%
|
-30.4%
|
-148.1%
|
Earnings before Tax (EBT)
1 |
-403.6
|
-657.9
|
-505.7
|
-64.74
|
-64.81
|
-158.1
|
Net income
1 |
-303.9
|
-530.5
|
-396.8
|
-64.37
|
-61.96
|
-152.2
|
Net margin
|
-1,823.22%
|
-5,823.38%
|
-5,229.88%
|
-92.26%
|
-167.77%
|
-340.14%
|
EPS
2 |
-0.6873
|
-1.107
|
-0.7160
|
-0.0800
|
-0.0371
|
-0.0342
|
Free Cash Flow
1 |
96.77
|
-114
|
22.02
|
-26.81
|
-43.25
|
-47.9
|
FCF margin
|
580.53%
|
-1,251.34%
|
290.28%
|
-38.42%
|
-117.11%
|
-107.05%
|
FCF Conversion (EBITDA)
|
184.47%
|
-
|
1,141.72%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/18
|
4/29/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
349
|
296
|
310
|
497
|
111
|
160
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.659
x
|
-3.714
x
|
160.5
x
|
33.27
x
|
13.57
x
|
-3.45
x
|
Free Cash Flow
1 |
96.8
|
-114
|
22
|
-26.8
|
-43.2
|
-47.9
|
ROE (net income / shareholders' equity)
|
-46.7%
|
-166%
|
275%
|
18.2%
|
34.8%
|
300%
|
ROA (Net income/ Total Assets)
|
-0.98%
|
-8.66%
|
-3.27%
|
0.22%
|
-1.93%
|
-16.9%
|
Assets
1 |
31,132
|
6,123
|
12,146
|
-29,787
|
3,215
|
901.4
|
Book Value Per Share
2 |
1.270
|
0.0900
|
-0.4400
|
-0.4000
|
0.0100
|
-0.0300
|
Cash Flow per Share
2 |
0.0700
|
0.0100
|
0.0100
|
0.0400
|
0.0200
|
0.0100
|
Capex
1 |
19.4
|
10.9
|
0.3
|
43.4
|
13
|
4.37
|
Capex / Sales
|
116.26%
|
119.73%
|
3.94%
|
62.18%
|
35.14%
|
9.77%
|
Announcement Date
|
4/26/18
|
4/29/19
|
4/27/20
|
4/27/21
|
4/27/22
|
4/26/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 13.68M | | -30.75% | 3.07B | | -15.97% | 2.52B | | +18.11% | 2.47B | | +3.70% | 2B | | -9.47% | 1.91B | | -2.22% | 1.47B | | +2.24% | 1.33B | | +18.92% | 1.19B | | +3.86% | 1.14B |
Medical Supplies
|